Harmony Biosciences
(NASDAQ:HRMY)
$29.50
0[0.00%]
At close: Apr 12
$29.50
0[0.00%]
PreMarket: 4:00PM EDT
Consensus Rating1
Buy
Highest Price Target1
$69.00
Lowest Price Target1
$27.00
Consensus Price Target1
$45.50

Harmony Biosciences Stock (NASDAQ:HRMY), Analyst Ratings, Price Targets, Predictions

Harmony Biosciences Holdings Inc has a consensus price target of $45.5, established from looking at the 61 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, Needham, and Needham on April 12, 2024, April 11, 2024, and April 9, 2024. With an average price target of $49.67 between Cantor Fitzgerald, Needham, and Needham, there's an implied 68.36% upside for Harmony Biosciences Holdings Inc from these 3 analyst ratings.

Analyst Trend
2
Jan
5
Feb
1
Mar
3
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Cantor Fitzgerald
Needham
Mizuho
Goldman Sachs
B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Harmony Biosciences

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
04/12/2024HRMYBuy Now
Harmony Biosciences
$29.5066.1%Cantor Fitzgerald
Charles Duncan
→ $49ReiteratesOverweight → OverweightGet Alert
04/11/2024HRMYBuy Now
Harmony Biosciences
$29.5069.49%Needham
Ami Fadia
→ $50ReiteratesBuy → BuyGet Alert
04/09/2024HRMYBuy Now
Harmony Biosciences
$29.5069.49%Needham
Ami Fadia
→ $50ReiteratesBuy → BuyGet Alert
03/28/2024HRMYBuy Now
Harmony Biosciences
$29.5066.1%Cantor Fitzgerald
Charles Duncan
→ $49ReiteratesOverweight → OverweightGet Alert
02/27/2024HRMYBuy Now
Harmony Biosciences
$29.5035.59%Mizuho
Graig Suvannavejh
$42 → $40MaintainsBuyGet Alert
02/23/2024HRMYBuy Now
Harmony Biosciences
$29.5066.1%Cantor Fitzgerald
Charles Duncan
→ $49ReiteratesOverweight → OverweightGet Alert
02/23/2024HRMYBuy Now
Harmony Biosciences
$29.5069.49%Needham
Ami Fadia
$53 → $50MaintainsBuyGet Alert
02/22/2024HRMYBuy Now
Harmony Biosciences
$29.5079.66%Needham
Ami Fadia
→ $53ReiteratesBuy → BuyGet Alert
02/16/2024HRMYBuy Now
Harmony Biosciences
$29.5042.37%Mizuho
Graig Suvannavejh
$33 → $42MaintainsBuyGet Alert
01/09/2024HRMYBuy Now
Harmony Biosciences
$29.50-5.08%Goldman Sachs
Corinne Jenkins
$25 → $28MaintainsSellGet Alert
01/02/2024HRMYBuy Now
Harmony Biosciences
$29.501.69%B of A Securities
Jason Gerberry
→ $30DowngradeNeutral → UnderperformGet Alert
11/01/2023HRMYBuy Now
Harmony Biosciences
$29.5079.66%Needham
Ami Fadia
→ $53ReiteratesBuy → BuyGet Alert
11/01/2023HRMYBuy Now
Harmony Biosciences
$29.50-8.47%Raymond James
Danielle Brill
$26 → $27MaintainsOutperformGet Alert
10/16/2023HRMYBuy Now
Harmony Biosciences
$29.5042.37%Piper Sandler
David Amsellem
$72 → $42MaintainsOverweightGet Alert
10/16/2023HRMYBuy Now
Harmony Biosciences
$29.5079.66%Needham
Ami Fadia
$66 → $53MaintainsBuyGet Alert
10/16/2023HRMYBuy Now
Harmony Biosciences
$29.50-11.86%Raymond James
Danielle Brill
$58 → $26MaintainsOutperformGet Alert
10/04/2023HRMYBuy Now
Harmony Biosciences
$29.5083.05%Mizuho
Graig Suvannavejh
→ $54ReiteratesBuy → BuyGet Alert
09/26/2023HRMYBuy Now
Harmony Biosciences
$29.505.08%Goldman Sachs
Corinne Jenkins
$40 → $31MaintainsSellGet Alert
09/25/2023HRMYBuy Now
Harmony Biosciences
$29.505.08%Goldman Sachs
Corinne Jenkins
$40 → $31DowngradeNeutral → SellGet Alert

FAQ

Q

What is the target price for Harmony Biosciences (HRMY)?

A

The latest price target for Harmony Biosciences (NASDAQ: HRMY) was reported by Cantor Fitzgerald on April 12, 2024. The analyst firm set a price target for $49.00 expecting HRMY to rise to within 12 months (a possible 66.10% upside). 37 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Harmony Biosciences (HRMY)?

A

The latest analyst rating for Harmony Biosciences (NASDAQ: HRMY) was provided by Cantor Fitzgerald, and Harmony Biosciences reiterated their overweight rating.

Q

When was the last upgrade for Harmony Biosciences (HRMY)?

A

The last upgrade for Harmony Biosciences Holdings Inc happened on October 14, 2022 when Jefferies raised their price target to $61. Jefferies previously had a hold for Harmony Biosciences Holdings Inc.

Q

When was the last downgrade for Harmony Biosciences (HRMY)?

A

The last downgrade for Harmony Biosciences Holdings Inc happened on January 2, 2024 when B of A Securities changed their price target from N/A to $30 for Harmony Biosciences Holdings Inc.

Q

When is the next analyst rating going to be posted or updated for Harmony Biosciences (HRMY)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Harmony Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Harmony Biosciences was filed on April 12, 2024 so you should expect the next rating to be made available sometime around April 12, 2025.

Q

Is the Analyst Rating Harmony Biosciences (HRMY) correct?

A

While ratings are subjective and will change, the latest Harmony Biosciences (HRMY) rating was a reiterated with a price target of $0.00 to $49.00. The current price Harmony Biosciences (HRMY) is trading at is $29.50, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch